Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Effect of more vs less frequent follow-up testing on overall and colorectal cancer-specific mortality in patients with Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Association of Blood Donor Sex and Prior Pregnancy With Mortality Among Red Blood Cell Transfusion Recipients

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. High-Dose Vitamin D Supplementation During Pregnancy and Asthma in Offspring at the Age of 6 Years

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Enhanced Recovery After Surgery in the United States: From Evidence-Based Practice to Uncertain Science?

    Research output: Contribution to journalEditorialResearchpeer-review

  1. Shoulder kinematics and kinetics of team handball throwing: A scoping review

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Propofol sedation in Drug Induced Sedation Endoscopy without an anaesthesiologist â€" a study of safety and feasibility

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Phenylephrine increases near-infrared spectroscopy determined muscle oxygenation during head-up tilt in men

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Pre-operative haemodynamic monitoring and resuscitation in hip fracture patients: Protocol for a prospective observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • COLOFOL Study Group
View graph of relations

Importance: Intensive follow-up of patients after curative surgery for colorectal cancer is common in clinical practice, but evidence of a survival benefit is limited.

Objective: To examine overall mortality, colorectal cancer-specific mortality, and colorectal cancer-specific recurrence rates among patients with stage II or III colorectal cancer who were randomized after curative surgery to 2 alternative schedules for follow-up testing with computed tomography and carcinoembryonic antigen.

Design, Setting, and Participants: Unblinded randomized trial including 2509 patients with stage II or III colorectal cancer treated at 24 centers in Sweden, Denmark, and Uruguay from January 2006 through December 2010 and followed up for 5 years; follow-up ended on December 31, 2015.

Interventions: Patients were randomized either to follow-up testing with computed tomography of the thorax and abdomen and serum carcinoembryonic antigen at 6, 12, 18, 24, and 36 months after surgery (high-frequency group; n = 1253 patients) or at 12 and 36 months after surgery (low-frequency group; n = 1256 patients).

Main Outcomes and Measures: The primary outcomes were 5-year overall mortality and colorectal cancer-specific mortality rates. The secondary outcome was the colorectal cancer-specific recurrence rate. Both intention-to-treat and per-protocol analyses were performed.

Results: Among 2555 patients who were randomized, 2509 were included in the intention-to-treat analysis (mean age, 63.5 years; 1128 women [45%]) and 2365 (94.3%) completed the trial. The 5-year overall patient mortality rate in the high-frequency group was 13.0% (161/1253) compared with 14.1% (174/1256) in the low-frequency group (risk difference, 1.1% [95% CI, -1.6% to 3.8%]; P = .43). The 5-year colorectal cancer-specific mortality rate in the high-frequency group was 10.6% (128/1248) compared with 11.4% (137/1250) in the low-frequency group (risk difference, 0.8% [95% CI, -1.7% to 3.3%]; P = .52). The colorectal cancer-specific recurrence rate was 21.6% (265/1248) in the high-frequency group compared with 19.4% (238/1250) in the low-frequency group (risk difference, 2.2% [95% CI, -1.0% to 5.4%]; P = .15).

Conclusions and Relevance: Among patients with stage II or III colorectal cancer, follow-up testing with computed tomography and carcinoembryonic antigen more frequently compared with less frequently did not result in a significant rate reduction in 5-year overall mortality or colorectal cancer-specific mortality.

Trial Registration: clinicaltrials.gov Identifier: NCT00225641.

Original languageEnglish
JournalJAMA - Journal of the American Medical Association
Volume319
Issue number20
Pages (from-to)2095-2103
Number of pages9
ISSN0002-9955
DOIs
Publication statusPublished - 22 May 2018

    Research areas

  • Adult, Aftercare/methods, Aged, Carcinoembryonic Antigen/blood, Colorectal Neoplasms/diagnosis, Female, Follow-Up Studies, Humans, Intention to Treat Analysis, Male, Middle Aged, Mortality, Neoplasm Recurrence, Local/diagnosis, Neoplasm Staging, Proportional Hazards Models, Survival Rate, Time Factors, Tomography, X-Ray Computed

ID: 55452597